Tom Melvin

911 total citations
26 papers, 419 citations indexed

About

Tom Melvin is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and General Health Professions. According to data from OpenAlex, Tom Melvin has authored 26 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in General Health Professions. Recurrent topics in Tom Melvin's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Biomedical Ethics and Regulation (4 papers) and Artificial Intelligence in Healthcare and Education (4 papers). Tom Melvin is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Biomedical Ethics and Regulation (4 papers) and Artificial Intelligence in Healthcare and Education (4 papers). Tom Melvin collaborates with scholars based in Ireland, United Kingdom and Germany. Tom Melvin's co-authors include Stephen Gilbert, Marina Torre, Hugh Harvey, Paul Wicks, Keith R. Briffa, Laura Cunningham, Rob Wilson, Richard J. Cooper, Neil J. Loader and Stuart Anderson and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Tom Melvin

24 papers receiving 400 citations

Peers

Tom Melvin

GPC

Flora Graham Australia

Rachael V. Phillips United States

Kevin Tang United States

James O’Connell Ireland

Jacqueline Vaughn United States

Jeremy Irvin United States

Brant W. Hager United States

James Hunter United States

Elliot A. Martin Canada

Rebecca Wilson United Kingdom

Flora Graham Australia

Tom Melvin

74 ×0.7

4 ×0.0

9 ×0.1

35 ×0.5

GPC

42 ×0.7

Citations per year, relative to Tom Melvin Tom Melvin (= 1×) peers Flora Graham

Countries citing papers authored by Tom Melvin

Since Specialization

Citations

This map shows the geographic impact of Tom Melvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Melvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Melvin more than expected).

Fields of papers citing papers by Tom Melvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Melvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Melvin. The network helps show where Tom Melvin may publish in the future.

Co-authorship network of co-authors of Tom Melvin

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Melvin. A scholar is included among the top collaborators of Tom Melvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Melvin. Tom Melvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McDonnell, Ann, et al.. (2025). Stakeholder Perspectives on Early Feasibility Studies for Digital Health Technologies in the European Union: Qualitative Interview Study. Journal of Medical Internet Research. 27. e77982–e77982.

Cobbaert, Christa M., Christian Schweiger, Christoph Buchta, et al.. (2025). Urgent call to the European Commission to simplify and contextualize IVDR Article 5.5 for tailored and precision diagnostics. Clinical Chemistry and Laboratory Medicine (CCLM). 63(12). 2366–2370. 2 indexed citations

Vasey, Baptiste, et al.. (2025). Safe AI-enabled digital health technologies need built-in open feedback. Nature Medicine. 31(2). 370–375. 2 indexed citations

Buccheri, Sergio, Stefan James, Marion Mafham, et al.. (2025). Large simple randomized controlled trials—from drugs to medical devices: lessons from recent experience. Trials. 26(1). 24–24. 1 indexed citations

Melvin, Tom, et al.. (2024). The regulatory status of health apps that employ gamification. Scientific Reports. 14(1). 21016–21016. 4 indexed citations

Melvin, Tom, Marc Dooms, Berthold Koletzko, et al.. (2024). Orphan and paediatric medical devices in Europe: recommendations to support their availability for on-label and off-label clinical indications. Expert Review of Medical Devices. 21(10). 893–901. 3 indexed citations

Algoet, Michiel, Tom Melvin, Johannes Bonatti, et al.. (2024). How to advance from minimally invasive coronary artery bypass grafting to totally endoscopic coronary bypass grafting: challenges in Europe versus United States of America. Annals of Cardiothoracic Surgery. 13(5). 397–408. 2 indexed citations

Melvin, Tom, Anne Lübbeke, Robert E. Geertsma, et al.. (2024). Safety notices and registry outlier data measure different aspects of safety and performance of total knee implants: a comparative study of safety notices and register outliers. Acta Orthopaedica. 95. 667–676.

Melvin, Tom, Nicolas Martelli, Simone Kühn, et al.. (2024). HPR98 The EU Regulatory Framework for Medical Device Early Feasibility Studies: What Do We Know to Date?. Value in Health. 27(12). S294–S294. 1 indexed citations

10.

Boyle, Gerry, et al.. (2024). Hospitals as medical device manufacturers: keeping to the Medical Device Regulation (MDR) in the EU. BMJ Innovations. 10(3). 74–80. 1 indexed citations

11.

Lübbeke, Anne, Christophe Combescure, Christophe Baréa, et al.. (2023). Clinical investigations to evaluate high-risk orthopaedic devices: a systematic review of the peer-reviewed medical literature. EFORT Open Reviews. 8(11). 781–791. 5 indexed citations

12.

Siontis, George C.M., Bernadette Coles, Jonas Häner, et al.. (2023). Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium. European Heart Journal. 45(3). 161–177. 14 indexed citations

13.

Patro-Gołąb, Bernadeta, et al.. (2023). Evidence from clinical trials on high-risk medical devices in children: a scoping review. Pediatric Research. 95(3). 615–624. 7 indexed citations

14.

Melvin, Tom, et al.. (2023). Can Apple and Google continue as health app gatekeepers as well as distributors and developers?. npj Digital Medicine. 6(1). 8–8. 14 indexed citations

15.

Gilbert, Stephen, et al.. (2023). Large language model AI chatbots require approval as medical devices. Nature Medicine. 29(10). 2396–2398. 112 indexed citations

16.

Gilbert, Stephen, et al.. (2023). Continuous Improvement of Digital Health Applications Linked to Real-World Performance Monitoring: Safe Moving Targets?. SHILAP Revista de lepidopterología. 1(3). 276–287. 12 indexed citations

17.

Gilbert, Stephen, et al.. (2023). Learning From Experience and Finding the Right Balance in the Governance of Artificial Intelligence and Digital Health Technologies. Journal of Medical Internet Research. 25. e43682–e43682. 33 indexed citations

18.

Melvin, Tom, et al.. (2022). Orphan Medical Devices and Pediatric Cardiology – What Interventionists in Europe Need to Know, and What Needs to be Done. Pediatric Cardiology. 44(2). 271–279. 13 indexed citations

19.

Melvin, Tom & Marina Torre. (2019). New medical device regulations: the regulator’s view. EFORT Open Reviews. 4(6). 351–356. 49 indexed citations

20.

Melvin, Tom. (1979). Practical psychology in construction management. Andalas University Repository (Andalas University). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact